News from mimedx, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 15, 2014, 08:45 ET

MiMedx Raises Expectations For 2015 Revenue To Range From $175 Million To $190 Million

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Dec 04, 2014, 09:00 ET

MiMedx To Present At The Oppenheimer 25th Annual Healthcare Conference

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 18, 2014, 08:00 ET

Thirteen Poster Abstracts Chronicling The Clinical Use, Cost Effectiveness And Accelerated Healing Results of MiMedx Products to be Presented by VA Physicians at Desert Foot Conference

 MiMedx Group, Inc. (NASDAQ: MDXG) announced today that fourteen poster abstracts chronicling the Company's dehydrated human...

Nov 17, 2014, 16:01 ET

Multi-Center Comparative Study Of MiMedx EpiFix® And Organogenesis Apligraf® Determines EpiFix Has Considerably Higher Rates Of Complete Healing And Significantly Faster Time To Heal

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 07, 2014, 09:39 ET

MiMedx® Adds New Executive

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Nov 05, 2014, 14:59 ET

MiMedx To Present At Two Healthcare Conferences

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 30, 2014, 07:30 ET

MiMedx Achieves Record Revenue And Records First Operating Profit

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 21, 2014, 12:07 ET

MiMedx Provides Update On Outstanding Patent Litigation

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 16, 2014, 10:07 ET

MiMedx At Fall 2014 SAWC: Studies And Key Opinion Leaders Present Clinical Evidence Of EpiFix Healing Results On Chronic And Acute Wounds

MiMedx Group, Inc. (NASDAQ: MDXG) EpiFix® dehydrated human amnion/chorion membrane (dHACM) allografts have been shown to be clinically...

Oct 13, 2014, 07:30 ET

MiMedx Third Quarter Revenue Of $33.5 Million Exceeds Upper End Of Guidance

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Oct 06, 2014, 16:29 ET

MiMedx Announces Release Date for 2014 Third Quarter Results

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Sep 30, 2014, 16:08 ET

MiMedx to Present at the Stem Cell Meeting on the Mesa

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Sep 24, 2014, 09:22 ET

Study Determines MiMedx Allograft Effectively Recruits Circulating Stem and Progenitor Cells

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Sep 18, 2014, 09:29 ET

MiMedx Signs Distribution Agreement With Zimmer

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Sep 17, 2014, 13:40 ET

MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Sep 08, 2014, 16:49 ET

MiMedx To Webcast Its Analyst Day On October 14th

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer  of  patent  protected...

Sep 03, 2014, 09:34 ET

Fifth MiMedx Scientific Study Published In Peer-Reviewed Journal

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Aug 04, 2014, 13:33 ET

MiMedx To Present At 34th Annual Canaccord|Genuity Growth Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 28, 2014, 23:00 ET

MiMedx Announces Record Second Quarter Results

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 23, 2014, 07:59 ET

MiMedx Files Its Initial Investigational New Drug Application

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...